Business Standard

BSE Sensex down, Bharti slides, pharmas gain

SENSEX-BHARTI-PHARMA:BSE Sensex down Bharti slides, pharmas gain

Related News

 

Reuters Market Eye - The falls 0.2 percent, while the 50-share Nifty declines 0.1 percent. Airtel falls 3.75 percent after Credit Suisse downgrades the stock to "underperform", citing the prospect Reliance Infotel would enter the wireless voice market and further hit margins in the sector.

Pharmaceutical stocks rise, with Laboratories up 3.3 percent, as a couple analyst reports cite improved sales potential in the key U.S. market.

Read more on:   
|
|
|
|
|

BSE Sensex down, Bharti slides, pharmas gain

SENSEX-BHARTI-PHARMA:BSE Sensex down Bharti slides, pharmas gain

Reuters Market Eye - The BSE Sensex falls 0.2 percent, while the 50-share Nifty declines 0.1 percent. Bharti Airtel falls 3.75 percent after Credit Suisse downgrades the stock to "underperform", citing the prospect Reliance Infotel would enter the wireless voice market and further hit margins in the sector.

 

Reuters Market Eye - The falls 0.2 percent, while the 50-share Nifty declines 0.1 percent. Airtel falls 3.75 percent after Credit Suisse downgrades the stock to "underperform", citing the prospect Reliance Infotel would enter the wireless voice market and further hit margins in the sector.

Pharmaceutical stocks rise, with Laboratories up 3.3 percent, as a couple analyst reports cite improved sales potential in the key U.S. market.

image

Read More

Sebi imposes fine on three persons for lack of disclosure

Pursuant to this purchase, their total holding rose to 11.2% in the company, crossing a threshold limit of 10% to attract the provisions of Sebi's ...

Recommended for you

Quick Links

Market News

RCom, BPCL plan to launch dollar bonds

For RCom, it will be second time the Ambani company is testing the investors' appetite for its paper

BSE currency options segment largest in the world

Number of contracts in currency options segment had grown by nearly 30% in March

Nifty ends down 101 points; TCS down 4%, Lupin slumps 7%

The 30-share Sensex ended down 224 points at 28,442 and the 50-share Nifty ended down 101 points at 8,606.

Sensex ends down 242 points; IT shares drag

The 30-share Sensex provisionally ended down 242 points at 28,425 and the 50-share Nifty ended down 104 points at 8,603.

Pharma shares extend fall; CNX Pharma index down 3%

Lupin, Aurobindo, Sun Pharma, Cadila Healthcare, Venus Remedies, SPARC & Shasun Pharma down were 3%-7%.

 

Back to Top